InsiderFlow

Andrew Callos

CYTK

Andrew Callos serves as officer: EVP, Chief Commercial Officer at Cytokinetics, Incorporated (CYTK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

31 trades

$15.08M

Net Position

Net Seller

$15.08M

Companies Traded

1

CYTK

Active Period

Feb 2023 – Jun 2026

31 total trades

Most Recent

Sell CYTK

Jun 1, 2026 · $1.11M

Andrew Callos's Insider Trading at Cytokinetics, Incorporated (CYTK)

Buys

0 · $0.00

Sells

31 · $15.08M

Total Shares Bought

0

Total Shares Sold

256,366

CYTK Price Chart
Loading chart...
DateTypeValue
Jun 1, 2026 Sell$1.11M
May 5, 2026 Sell$875.5K
May 4, 2026 Sell$1.03M
Apr 30, 2026 Sell$948.9K
Apr 15, 2026 Sell$491.8K
Mar 31, 2026 Sell$236.5K
Mar 18, 2026 Sell$650.7K
Mar 16, 2026 Sell$104.3K
Mar 10, 2026 Sell$156.8K
Mar 2, 2026 Sell$54.6K
Feb 5, 2026 Sell$929.0K
Feb 2, 2026 Sell$55.0K
Jan 5, 2026 Sell$904.2K
Jan 2, 2026 Sell$112.6K
Dec 29, 2025 Sell$113.0K
Dec 22, 2025 Sell$42.3K
Dec 8, 2025 Sell$68.7K
Dec 5, 2025 Sell$3.46M
Dec 3, 2025 Sell$88.9K
Jun 5, 2025 Sell$277.4K
May 5, 2025 Sell$146.8K
Apr 7, 2025 Sell$103.3K
Mar 17, 2025 Sell$1.07M
Mar 14, 2025 Sell$4.5K
Mar 13, 2025 Sell$1.17M
Mar 6, 2025 Sell$144.6K
Mar 3, 2025 Sell$47.8K
Dec 3, 2024 Sell$69.6K
Mar 4, 2024 Sell$490.3K
Mar 2, 2023 Sell$87.2K
Feb 16, 2023 Sell$42.8K